Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology: Results of the 24th Prioritisation – 3rd quarter 2015. HSO: 24th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 24th prioritisation (September 2015), 7 were filtered out of 191 identified drugs and were sent to prioritisation. Of these, 2 drugs were ranked as 'highly relevant' by the expert panel, 4 as 'relevant' and 1 as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
|Series Name:||HSO: 24th Prioritisation|
|Deposited on:||03 Nov 2015 16:26|
|Last Modified:||24 Aug 2017 15:22|
Repository Staff Only: item control page